News + PR
Bushu Pharmaceuticals will participate in CPHI Worldwide 2022 in Frankfurt for the first time in three years.
Bushu Pharma is thrilled to be participating at this year’s CPHI Worldwide 2022 in Frankfurt for the first time in three years.
Talk to us about our Gateway to Asia supply chain services that will allow you to expand into Japan and Asia.
With Japan and Asia such an attractive market, this will be an ideal opportunity for your business expansion.
We look forward to seeing you!
Bushu Pharmaceuticals Ltd. (Kawagoe City, Saitama Prefecture) is pleased to announce the completion of the transfer of FUKUSHIMA Factory’s business from Sanwa Kagaku Kenkyusho Co., Ltd.
With the completion of the business transfer, the name of the factory will be changed to Aizu Factory, and it will help further growth as an important production base for Bushu Pharmaceuticals, which provides high quality pharmaceutical products as a contract manufacturing factory.
LogiPharma has been bringing together the top minds in life sciences and healthcare supply chain, logistics, distribution, planning, IT, quality and sourcing to share emerging best practices.
At this event, Bushu Pharma will have an exhibition booth and shall also give a presentation at 3.25pm on the first day of the event during the “Spot Innovation” program to introduce its unique supply chain management services,” Gateway to Asia” and contract manufacturing services. (Presenter: Susan Lynch-Smith, Head of Business Development & Marketing, N.A. and Europe)
Bushu Pharmaceuticals has been recognized by Frost & Sullivan, an independent research and consulting firm, as a market leader in the pharmaceutical contract manufacturing industry. As a result, the company received the “2022 Japan Pharmaceutical Contract Manufacturing and Supply Chain Market Leadership Customer Value Award”.
Bushu Pharmaceuticals will participate in the AMERICAN PHARMA OUTSOURCING SUMMIT for the first time.
The summit is designed to provide pharmaceutical executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics.
At the Summit, Bushu Pharma will have an exhibition booth to introduce the unique supply chain management services, Gateway to Asia, and contract manufacturing services.
Bushu Pharmaceuticals Co. Ltd. (Kawagoe City, Saitama Prefecture, Japan) is pleased to announce that Mr. Kazuhisa Wakao will be joining us as Senior Vice President and Plant Manager of FUKUSHIMA Factory, effective as of September 1, 2022, subject to…
What will we be exhibiting at INTERPHEX JAPAN 2022? GATEWAY to ASIA, Cold Chain Center services, and more…
After taking a long break from doing public exhibits while facing the impact of COVID-19, Bushu Pharma is thrilled to be exhibiting again at this year’s INTERPHEX JAPAN. We will be sharing lots of updates, including the latest information on…
Bushu Pharma will participate in the upcoming 24th INTERPHEX JAPAN 2022 for the first time in three years. Set to take place on July 13 – 15 at the Tokyo Big Sight convention center, numerous companies involved in the production of pharmaceutical products will exhibit at the show. Bushu Pharma will introduce the facilities, plants, and services that have been added to our capabilities over the past three years.
Hideyuki Tanaka – Bushu Pharma’s Head of Global Business Development and Marketing Strategy – will be a guest speaker at the 7th Pharma Supply Chain and Logistics Innovation Programme, taking place on 10-11 May 2022 in Basel, Switzerland. His session entitled “GATEWAY to ASIA – effective supply chain management approaching to Asian market for your innovative drugs”…
Notice Concerning Conclusion of Business Transfer Agreement: Sanwa Kagaku Kenkyusho’s Fukushima Factory Business Transferring to Bushu Pharmaceuticals
Sanwa Kagaku Kenkyusyo CO., LTD. (President / CEO: Shusaku Isono, Suzuken Group; hereinafter referred to as “Sanwa Kagaku”) today announced that it has signed an agreement with Bushu Pharmaceuticals Ltd.（Tetsuichi Okada, CEO / Executive Chairman） for the transfer of business of Fukushima Factory.